NVCT
Nuvectis Pharma, Inc. · Healthcare
Chair and CEO Ron Bentsur bought $250K of Nuvectis Pharma, Inc.
Bought$250,000
$20.00Price
12,500Shares
0%Stake
What NVCT did for a copier
- $1,000 copied at Wed, Jul 1 close, $19.52
- $985
- S&P 500, same days
- +4.3%
Measured over 30 trading days, to the Aug 13 close.
Ron Bentsur's record
11 other buys with 3 months of prices since 2022: on average +59.5% against the S&P 500, and 7 of 11 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jun 30. Filed Wed, Jul 1, 1:39 PM ET, during the session. Returns use the Jul 1 close and the Aug 13 close. Not investment advice.